Trials / Suspended
SuspendedNCT04113213
Primary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health
Primary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health (Phase II)
- Status
- Suspended
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- University of South Wales · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Prescribing lifestyle changes to patients who are at risk of cardiovascular disease, may be an extremely cost effective mechanism of improving health for the individual themselves and the NHS. It is already proven that positive lifestyle changes such as improved diet, increased physical activity, quitting smoking and reducing alcohol consumption can lower the risk of cardiovascular disease, as well as reduce the risk of all-cause mortality. P-PLAC2 (Primary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health) is a Phase II interventional study to determine the efficacy of a Lifestyle Prescription (LRx), from the viewpoint of patients and healthcare practitioners. The study uses a mixed methods design, and full study training and support will be provided to staff involved in the recruitment of patients, through to the behaviour change consultation, and end of study. If the study proves successful, a lifestyle prescription (LRx) could then be made available to support NHS staff throughout all disciplines (specifically those working with patients who are at risk of cardiovascular disease (CVD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Lifestyle Prescription (LRx) | Lifestyle prescription, based on the UK WP10 medicinal prescription form. Includes advice and guidance regarding physical activity, diet, smoking and alcohol consumption. |
Timeline
- Start date
- 2019-10-05
- Primary completion
- 2022-12-31
- Completion
- 2023-01-31
- First posted
- 2019-10-02
- Last updated
- 2021-06-30
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04113213. Inclusion in this directory is not an endorsement.